Biotech

All Articles

Neurocrine's bid to conserve schizophrenia prospect stops working

.Neurocrine Biosciences' schizophrenia system pivot has actually failed. The biotech was actually un...

Sanofi spends $110M upfront for late-stage radioligand therapy

.Sanofi has made an overdue access to the radioligand party, paying 100 thousand euros ($ 110 thousa...

F 2G brings up $100M for second effort to receive brand-new antifungal to market

.After F2G's initial attempt to obtain a brand-new lesson of antifungal to market was actually hinde...

Moderna targets $1.1 B in R&ampD spending slices, drops 5 plans in the middle of profits tensions

.Moderna has actually vowed to reduce R&ampD spending by $1.1 billion through 2027. The choice to sh...

Sanofi's $80M bank on Key dystrophy medication ends in stage 3 go belly up

.Simply 4 months after Sanofi bet $80 million in beforehand cash on Pivot Therapies' losmapimod, the...

Oncternal stock drains 60% amidst discharges, test discontinuations

.Cancer cells provider Oncternal Therapies is actually folding all its own professional tests and la...

Roche is supporting out chances that its own injectable obesity prospect can eventually show 25% weight-loss in late-stage test

.Roche is holding out hopes that its injectable excessive weight possibility might eventually demons...

Novo Nordisk hails 'remarkable' weight-loss result for dual-acting dental drug in very early test

.Novo Nordisk has actually raised the top on a period 1 trial of its own oral amylin and GLP-1 recep...

AbbVie takes legal action against BeiGene over blood stream cancer medication secret method

.Merely a couple of quick weeks after gaining an FDA Fast lane tag for its own investigational BTK d...

Lilly supplies one-two punch with 2nd tranche of good information on weekly insulin candidate

.Not long after a positive information drop for Eli Lilly's efsitora alfa, the Indianapolis-based pr...